Pimozide
پیموزاید
🧠 Nervous SystemDiphenylbutylpiperidine antipsychotic
Market / country: 🇺🇸 USA
Orap (US)
🧮 Dose calculator
Tourette's disorder · Regimen source: FDA Pimozide · Dosage and Administration
🛡️ Safety & information
Contraindications
- ⛔ Simple tics or tics other than Tourette; tic-causing drugs (methylphenidate, amphetamines) until withdrawn; congenital long QT, history of arrhythmia, QT-prolonging drugs, hypokalaemia or hypomagnesaemia; severe CNS depression or coma; hypersensitivity; macrolides and other CYP3A4 inhibitors (azoles, protease inhibitors). FDA Pimozide · Contraindications
Warnings
- • QT prolongation and sudden death; tardive dyskinesia; NMS. FDA Pimozide · ContraindicationsFDA Pimozide · Warnings
Formulations
- 1 mg tablet (scored) — tablet 🇺🇸 USA FDA Pimozide · How Supplied
- 2 mg tablet (scored) — tablet 🇺🇸 USA FDA Pimozide · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Pimozide · Pregnancy:
“Pimozide should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Pimozide · Nursing Mothers
“Because many drugs are excreted in human milk and because of the potential for tumorigenicity and unknown cardiovascular effects in the infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Pimozide · Pediatric Use
“Although Tourette's Disorder most often has its onset between the ages of 2 and 15 years, information on the use and efficacy of pimozide in patients less than 12 years of age is limited.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA204521
- DailyMed (FDA label)FDA Pimozide
- MedlinePlus (NIH)Pimozide
- WHO ATC/DDDN05AG02
- Darooyab (Iran)Pimozide
🇮🇷 Registered in Iran Darooyab · G-1328/Pimozide
Dosage forms with Iranian generic codes, per Darooyab.
- 01997 · PIMOZIDE 2MG TAB · قرص پیموزاید ۲ میلیگرم
- 01009 · PIMOZIDE 4MG TAB · قرص پیموزاید ۴ میلیگرم
- 51964 · PIMOZIDE 1MG TAB · قرص پیموزاید ۱ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Pimozide · How SuppliedFDA Pimozide · Dosage and AdministrationFDA Pimozide · ContraindicationsFDA Pimozide · WarningsFDA Pimozide · SPL approval / marketing categoryFDA Pimozide · Pregnancy:FDA Pimozide · Nursing MothersFDA Pimozide · Pediatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1328/Pimozide
- Clinical review⚠ Unverified